Summary of Vizsla Royalties Conference Call Company Overview - **Company**: Vizsla Royalties (OTCPK: VROY.F) - **Business Model**: Single asset royalty company holding a precious metals NSR royalty covering Vizsla Silver's Panuco project in Mexico [1] Industry Context - **Market Conditions**: Current all-time highs in gold prices and 15-year highs in silver prices at $42 per ounce [3] - **M&A Activity**: Recent precedent transactions in the royalty space suggest significant premiums, indicating a favorable environment for royalty companies [3][12] Core Project Insights - **Panuco Project**: - Considered the highest grade undeveloped silver primary resource globally [1] - If in production, it would be the third largest silver primary mine in the world [1] - Development stage with a Preliminary Economic Assessment (PEA) published in 2024, targeting first silver production in the second half of 2027 [2] - **Resource Base**: - Over 365 million ounces of silver equivalent identified, with only 30% of known targets tested [2][5] - PEA mine plan accounts for about 10% of known veins [2] - **Financial Position**: - Vizsla Silver has over $200 million in cash, no debt, and a project finance mandate for an additional $200 million [5] - Low capital expenditure (CapEx) hurdle of $224 million [5] Production and Exploration Potential - **Production Profile**: - PEA production profile indicates over 20 million ounces per annum in initial years [6] - Anticipated increase in resource estimates from 156 million ounces in the PEA to 222 million ounces in the upcoming feasibility study, representing a 43% increase at a 5% higher grade [6] - **Exploration Upside**: - Significant exploration potential exists as all 11 resource structures are open in every direction [8] - Recent discoveries, such as at Animas, support the potential for additional high-grade mineralization [9] Strategic Advantages - **Royalty Structure**: - Holds a 3.5% net smelter return (NSR) royalty and an additional 2% NSR on exploration concessions [3] - Right of first refusal on any additional royalties created by Vizsla Silver within 24 months [4] - **Non-Dilutive Growth**: - The royalty model allows for growth without the need for further capital outlay or dilution for shareholders [10] Valuation and Market Position - **Valuation Metrics**: - Current trading at approximately 1.1 times NAV, compared to acquisition multiples averaging around 1.6 times for similar companies [12] - Potential for re-rating as the project progresses and de-risks [12] - **Peer Comparison**: - Major royalty players trade at significant premiums, suggesting potential for Vizsla Royalties to be valued higher as the project advances [11] Conclusion - **Investment Thesis**: - Vizsla Royalties presents a compelling investment opportunity due to its high-quality asset, favorable market conditions, and significant exploration upside [13] - **Future Outlook**: - Anticipated milestones include the imminent feasibility study and expected permitting approvals, positioning the company for growth as it approaches production [10]

Summary of Royalty Pharma FY Conference Call Company Overview - **Company**: Royalty Pharma (NasdaqGS:RPRX) - **Industry**: Biopharmaceutical royalties - **Market Position**: Largest buyer of biopharmaceutical royalties globally with over 50 products in its portfolio [7][9] - **Financial Metrics**: - Portfolio receipts guidance for 2025: $3.1 billion - Cash flow guidance for 2025: $2.5 billion - Market capitalization: over $20 billion - CAGR of royalty receipts: 12% since IPO [9][10][21] Core Business Model - **Investment Strategy**: Focus on high-quality, important medicines with strong data; operates as a generalist team to evaluate diverse therapeutic areas [16][27][29] - **Capital Allocation**: - $14 billion deployed since IPO - $4 billion returned through buybacks and repurchases [10][11] - **Royalty Types**: - Traditional royalties from licensing transactions - Synthetic royalties created through direct investments in companies [19][20] Growth and Market Dynamics - **Market Expansion**: Significant growth in biotech innovation leading to increased demand for diverse capital sources [11][12] - **Financial Targets**: - Portfolio receipt CAGR target of 10% or more from 2020 to 2030, currently tracking at 12% [21] - Capital deployment target of $10 billion to $12 billion over five years, already exceeding this target [22] - **Investment Returns**: - Unlevered IRR targets: high single to low double digits for approved products, teens for development stage products [23][24] Recent Transactions and Innovations - **Revolution Medicines Deal**: - $2 billion partnership allowing Revolution Medicines to maintain independence while providing significant capital for development [45][50] - Unique structure with upfront and milestone-based funding, including senior secured debt [51][52] - **Investment in Diverse Areas**: - Focus on underrepresented therapeutic areas such as migraine and psychiatry, with investments in CGRP and long-acting injectable products [36][37] Competitive Landscape - **Market Positioning**: - Unique evergreen business model allowing for lower cost of capital and flexibility in investments [40][41] - Emphasis on creating a vibrant marketplace for royalties, welcoming competition while maintaining a leadership position [43][44] Future Outlook - **Market Opportunities**: - Fragmentation in the biotech sector and increased innovation create ongoing opportunities for royalty transactions [58][59] - Potential for new royalties from licensing activities in emerging markets like China [62] - **Deal Structure Innovations**: - Plans to explore earlier-stage investments and innovative funding structures to adapt to market needs [71][72] Key Takeaways - Royalty Pharma is well-positioned in a growing market with a strong track record of capital allocation and investment returns - The company is focused on maintaining its leadership in the biopharmaceutical royalty space through innovative deal structures and strategic partnerships - Future growth is anticipated through continued investment in diverse therapeutic areas and adapting to market dynamics

Summary of Conference Call Records Company Overview - **Vizsla Royalties (VROY.F)**: A single asset precious metals royalty holder with its principal asset being the Canuco Project, which is part of Vizsla Silver's flagship silver and gold development in Mexico [1][2] - **Star Gold Corp (SRGZ)**: A junior mining company based in Nevada focused on the exploration and development of high-quality mineral properties [22] Key Points from Vizsla Royalties - **Investment Thesis**: The investment opportunity is based on three main aspects: 1. Upside potential as Vizsla Silver advances the Canuco Project towards feasibility and production, expected to start in 2027 [2] 2. Significant exploration upside with 93 kilometers of cumulative vein strike, of which only 8% is included in the current mine plan [3] 3. Scarcity of tier one silver assets, with no other tier one silver royalties outside of the major three royalty companies [3] - **Royalty Ownership**: Increased royalty ownership on the Panuco asset to 3.5% covering the mine plan and an additional 2% covering exploration potential [4][5] - **Financial Position**: Vizsla Silver is well-funded with approximately $200 million in cash, allowing for non-dilutive project advancement with a modest capital expenditure (CapEx) of $224 million [7] - **Resource Growth**: The Panuco project has outlined a global resource base of over 360 million ounces of silver equivalent, with significant potential for further resource expansion [10] - **Production Profile**: The mine plan indicates production of approximately 20 million ounces in the initial years, dropping to 15 million ounces over the project's life, positioning it among the largest silver mines globally [11][12] - **Valuation and Market Position**: Current trading at 1.1 times price to net asset value (NAV), with potential valuation upwards of $350-400 million based on recent comparable transactions in the royalty space [19][20] Key Points from Star Gold Corp - **Unique Financing Model**: Majority of financing comes from directors and officers, differentiating it from other junior mining companies [22][23] - **Focus on Main Zone**: Concentration on proving enough ore in the main zone to move into production, with an estimated 100,000 recoverable ounces of gold [24] - **Economic Viability**: Initial PEA conducted at $1,500 gold indicated a net present value (NPV) of $52 million, with projections over $100 million at $2,700 gold [31][32] - **Permitting Process**: Plan of operation filed on August 6, with expectations for final permits within two years, contingent on completing necessary drilling and environmental studies [28][30][33] - **Next Steps**: Focus on production water drilling and final engineering plans to expedite the permitting process [34] Additional Important Information - **Exploration Potential**: Both companies highlight significant exploration upside, with Vizsla emphasizing the potential for additional high-grade mineralization and Star Gold focusing on expanding its resource base [3][13][24] - **Market Timing**: The current market conditions for silver and gold are favorable, enhancing the potential for cash flow generation and project advancement for both companies [3][20]

Core Viewpoint - Silver Crown Royalties Inc. reported its interim financial results for Q2 2025, highlighting a decrease in silver royalty income compared to the previous quarter but a significant increase year-over-year [2][4]. Financial Performance - In Q2 2025, the company recorded 5,593 silver ounces as royalty income, amounting to C$267,350, which is a 148% increase from C$107,785 in Q2 2024 but a 12% decrease from C$304,408 in Q1 2025 [2][4]. - The year-over-year change in attributable silver deliveries was 105%, while the quarter-over-quarter change was a decrease of 16.5% [4]. Strategic Initiatives - The CEO noted that Q2 2025 saw 13-year high silver prices, presenting both challenges and opportunities for the company [3]. - The company is focused on adding silver ounces to its portfolio at attractive prices and rates of return, with plans to advance several Letters of Intent (LOIs) in the second half of 2025 [3]. Operational Updates - The company is facing challenges with Gold Mountain Mining Corp. and its subsidiaries, which are under receivership, affecting outstanding payments of C$140,588.53 owed to Silver Crown [6]. - Pilar Gold Inc. has delayed the restart of commercial operations at the PGDM Complex in Brazil to Q4 2025, with C$541,756.03 in minimum accrued royalty payments currently due to Silver Crown [6]. Company Overview - Silver Crown Royalties Inc. is a publicly traded silver royalty company that aims to generate free cash flow and provide investors with exposure to precious metals [7]. - The company currently holds five silver royalties and seeks to minimize the economic burden on mining projects while maximizing shareholder returns [7].

Financial Data and Key Metrics Changes - Ore Royalty earned 19,700 GEOs in Q2 2025, a modest increase from Q1, on track to meet the full year guidance of 80,000 to 88,000 GEOs [3] - Quarterly revenues reached $60.4 million, an increase compared to the same period last year, driven by higher commodity prices [6] - Net earnings improved to $0.17 per basic common share, a significant year-over-year improvement from a loss in the previous year [6] - Cash flow per share increased to $0.27 from $0.21 in Q2 of last year, and adjusted earnings rose to $0.18 from $0.13 [6] - The company ended Q2 with $49.6 million in cash and achieved a net cash position for the first time in several years [4] Business Line Data and Key Metrics Changes - Over 93% of GEOs earned came from precious metals, with a modest increase in copper contribution primarily from the CSA mine [6][7] - Canadian Malartic had a strong quarter, with expectations for continued performance in the second half of the year [8] - Mantos Blancos production was flat year-over-year, with expectations for silver grades to improve in the second half [8][9] Market Data and Key Metrics Changes - The gold-silver ratio tightened to approximately 89:1 from highs of 105:1 earlier in the year, indicating potential leverage for investors in silver [11] - Ore Royalty's revenues were predominantly generated from Tier one mining jurisdictions, including Canada, the U.S., and Australia [12] Company Strategy and Development Direction - The company is focused on disciplined capital allocation to pursue high-quality accretive streams and royalties [30] - Ore Royalty aims to enhance its portfolio with producing assets while remaining selective about development stage royalties [37] - The company is optimistic about the potential of the second shaft at Odyssey, which could significantly increase gold production [25] Management's Comments on Operating Environment and Future Outlook - Management expects a stronger second half of 2025, with Canadian Malartic and Nandimi contributing to increased GEO sales [33][34] - The corporate development team is stretched to capacity, focusing on high-quality assets that will contribute to GEOs within the next five years [38] - The company is optimistic about the Cariboo project and its potential contributions to future revenue [51] Other Important Information - Ore Royalty declared and paid a quarterly dividend of $0.55 per share, marking its 43rd consecutive dividend [5] - The company has a total debt of just under $36 million and a net cash position of $14 million, with potential liquidity exceeding $900 million [16][30] Q&A Session Summary Question: Can you provide more color on the second half of this year and where the incremental GEO sales are coming from? - Management expects most of the increase to come from Canadian Malartic and Mantos Blancos, with additional contributions from Nandimi [33][34] Question: Is there a preference for producing versus development stage royalties? - The first preference is for accretive deals on producing assets, but the company is also looking at high-quality development assets that will contribute within five years [36][38] Question: What criteria are considered for the new five-year guidance? - Key criteria include confidence in asset contributions to GEOs, financing visibility, and social license [42][45] Question: How does the company view larger transactions in the $1 billion range? - The company is open to significant transactions if they meet economic returns for shareholders, with $900 million in available liquidity [47] Question: What is the current status of Elliott's holdings? - The last public disclosure indicates Elliott owns 2.2 million shares, with no further updates available [63][65]

Financial Performance & Growth - Elemental Altus anticipates record adjusted revenue between US$30.1 million and US$34.3 million in 2025 [12] - The company projects a 50% increase in adjusted revenue from royalties, reaching US$32 million in 2025 [13, 65] - Elemental Altus has a track record of growing revenue each year since its inception [15, 65] Portfolio & Assets - The company's portfolio includes 10 producing assets and over 70 exploration and development stage royalties [12, 71] - Karlawinda and Caserones contribute approximately 40% of Elemental Altus's Asset Net Asset Value (NAV) [19] - The Karlawinda mine has seen a 15% increase in reserves since royalty acquisition [27] Capital & Valuation - Elemental Altus has over US$80 million of non-dilutive capital available for deployment from cash and an undrawn credit facility [13, 64] - The company has a US$50 million available from a credit facility with senior Canadian banks [58, 66] - The company's market capitalization is approximately US$350 million [12, 59] Strategic Initiatives - Elemental Altus acquired a 0.54% NSR royalty for US$10 million on Arizona Sonoran's Cactus mine [51] - The company received maiden revenue of US$6.6 million from the Korali-Sud royalty [13, 39] - Elemental Altus has an NCIB (Normal Course Issuer Bid) in place and available for use [13]